1 research outputs found
The top 50 drugs in the UK and Japan: why are they so different?
- Author
- A Kumagai
- A Kumagai
- British Hospital Index
- British National Formulary No 22.
- British National Formulary No 24
- British Pharmaceutical Index
- Dept. of Social Statistics Ministry of Health and Welfare
- E Ohtomo
- E Ohtomo
- E Ohtomo
- E Ohtomo
- F Ichita
- FX-505 project for Phase III study
- H Kishi
- H Kobayashi
- H Kobayashi
- H Kobayashi
- Handbook of Medicines
- I Fujimori
- J Arata
- J Atarashi
- J Ishigami
- J Ishigami
- J Ishigami
- J Kumazawa
- J Yura
- Japan Medical Data Index
- Japan Pharmaceutical Market
- K Fujita
- K Hirohata
- K Ishii
- K Ishii
- K Kawal
- K Konno
- K Konno
- K Matsumoto
- K Matsumoto
- K Matsumoto
- K Ohizumi
- K Shiba
- K Shiba
- K Shichikawa
- K Ueie
- M Horii
- M Murakami
- M Ohkoshi
- M Saito
- N Ogata
- New Drugs Division Japanese Ministry of Health and Welfare
- New Drugs Division Japanese Ministry of Health and Welfare
- New Drugs Division Japanese Ministry of Health and Welfare edn
- Office of Population Censuses and Surveys
- R Soejima
- S Arakawa
- S Baba
- S Kawamura
- S Kobayashi
- S Serizawa
- T Aoki
- T Katsumura
- T Katumura
- T Sakita
- T Sasaki
- T Yasugi
- The Association of the British Pharmaceutical Industries
- The Official Book Society of Japan edn
- Y Agishi
- Y Goto
- Y Hirasawa
- Y Itami
- Y Itami
- Y Kawada
- Y Kawada
- Y Saito
- Y Tasaki
- Z Takase
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- 01/01/1994
- Field of study